Conventional Synthetic Disease-Modifying Anti-rheumatic Drugs for Psoriatic Arthritis: Findings and Implications From a Patient Centered Longitudinal Study in Brazil

Background: Conventional synthetic disease-modifying antirheumatic drugs are the first-line treatment to inhibit the progression of psoriatic arthritis. Despite their widespread clinical use, few studies have been conducted to compare these drugs for psoriatic arthritis. Methods: a longitudinal stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Faria, Ronaldo José, Cordeiro, Francisca Janiclecia Rezende, dos Santos, Jéssica Barreto Ribeiro, Alvares-Teodoro, Juliana, Guerra Júnior, Augusto Afonso, Acurcio, Francisco de Assis, da Silva, Michael Ruberson Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086188/
https://www.ncbi.nlm.nih.gov/pubmed/35559237
http://dx.doi.org/10.3389/fphar.2022.878972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086188/
https://www.ncbi.nlm.nih.gov/pubmed/35559237
http://dx.doi.org/10.3389/fphar.2022.878972

Ejemplares similares